Parkinson's disease: Clinical aspects

Cell and Tissue Research

Volumn 318, Issue 1, 2004, Pages 115-120

  Klockgether, Thomas ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

synuclein; Akinesia; Lewy bodies; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN;

AKINESIA; CLINICAL EXAMINATION; CLINICAL FEATURE; HUMAN; LEWY BODY; MUSCLE RIGIDITY; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING; TREMOR;

HUMANS; MESENCEPHALON; NERVE DEGENERATION; PARKINSON DISEASE;

EID: 5444269702     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-004-0975-6     Document Type: Review

References (52)

1. Benabid AL, Pollak P, Seigneuret E, Hoffmann D, Gay E, Perret J (1993) Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias. Acta Neurochir Suppl (Wien) 58:39-44
2. Benecke R, Rothwell JC, Dick JP, Day BL, Marsden CD (1986) Performance of simultaneous movements in patients with Parkinson's disease. Brain 109:739-757
3. Benecke R, Rothwell JC, Dick JP, Day BL, Marsden CD (1987) Disturbance of sequential movements in patients with Parkinson's disease. Brain 110:361-379
4. Berardelli A, Dick JP, Rothwell JC, Day BL, Marsden CD (1986) Scaling of the size of the first agonist EMG burst during rapid wrist movements in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 49:1273-1279
5. Berendse HW, Booij J, Francot CM, et al (2001) Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell. Ann Neurol 50:34-41
6. Bergman H, Deuschl G (2002) Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back. Mov Disord 17(Suppl 3):S28-S40
7. Boose A, Spieker S, Jentgens C, Dichgans J (1996) Wrist tremor: investigation of agonist-antagonist interaction by means of long-term EMG recording and cross-spectral analysis. Electroencephalogr Clin Neurophysiol 101:355-363
8. Botzel K, Schulze S (1996) Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 119:1045-1048
9. Braak H, Del Tredici K (2004) Poor and protracted myelination as a contributory factor to neurodegenerative disorders. Neurobiol Aging 25:19-23
10. Braak H, Del Tredici K, Rub U, Vos RA de, Jansen Steur EN, Braak E (2003a) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197-211
11. Braak H, Rub U, Gai WP, Del Tredici K (2003b) Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110:517-536
12. Brown VJ, Schwarz U, Bowman EM, Fuhr P, Robinson DL, Hallett M (1993) Dopamine dependent reaction time deficits in patients with Parkinson's disease are task specific. Neuropsychologia 31:459-469
13. Burn DJ (2002) Depression in Parkinson's disease. Eur J Neurol 9 (Suppl 3):44-54
14. Cody FW, MacDermott N, Matthews PB, Richardson HC (1986) Observations on the genesis of the stretch reflex in Parkinson's disease. Brain 109:229-249
15. Delwaide PJ, Pepin JL, Maertens dN (1991) Short-latency autogenic inhibition in patients with Parkinsonian rigidity. Ann Neurol 30:83-89
16. Deuschl G, Lucking CH (1990) Physiology and clinical applications of hand muscle reflexes. Electroencephalogr Clin Neurophysiol Suppl 41:84-101
17. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI (1992) Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 55:138-142
18. Evarts EV, Teravainen H, Calne DB (1981) Reaction time in Parkinson's disease. Brain 104:167-186
19. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, et al (2001) Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344:710-719
20. Gibb WR, Lees AJ (1989) The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol 15:27-44
21. Hague K, Lento P, Morgello S, Caro S, Kaufmann H (1997) The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. Acta Neuropathol (Berl) 94:192-196
22. Hallett M, Khoshbin S (1980) A physiological mechanism of bradykinesia. Brain 103:301-314
23. Henderson JM, Yiannikas C, Morris JG, Einstein R, Jackson D, Byth K (1994) Postural tremor of Parkinson's disease. Clin Neuropharmacol 17:277-285
24. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184
25. Hughes AJ, Daniel SE, Lees AJ (2001) Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 57:1497-1499
26. Jahanshahi M, Jenkins IH, Brown RG, Marsden CD, Passingham RE, Brooks DJ (1995) Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 118:913-933
27. Koller WC (1992) When does Parkinson's disease begin? Neurology 42:27-31
28. Koller WC, Vetere-Overfield B, Barter R (1989) Tremors in early Parkinson's disease. Clin Neuropharmacol 12:293-297
29. Kruger R, Kuhn W, Muller T, et al (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18:106-108
30. Lee RG, Tatton WG (1975) Motor responses to sudden limb displacements in primates with specific CNS lesions and in human patients with motor system disorders. Can J Neurol Sci 2:285-293
31. Lees AJ (1992) When did Ray Kennedy's Parkinson's disease begin? Mov Disord 7:110-116
32. Lees AJ, Smith E (1983) Cognitive deficits in the early stages of Parkinson's disease. Brain 106:257-270
33. Levy G, Schupf N, Tang MX, et al (2002) Combined effect of age and severity on the risk of dementia in Parkinson's disease. Ann Neurol 51:722-729
34. Litvan I, Bhatia KP, Burn DJ, et al (2003) Movement Disorders Society Scientific Issues Committee report: SIC task force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord 18:467-486
35. Marder K, Tang MX, Cote L, Stern Y, Mayeux R (1995) The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol 52:695-701
36. Marsden CD, Rothwell JC, Day BL (1983) Long-latency automatic responses to muscle stretch in man: origin and function. Adv Neurol 39:509-539
37. Mayeux R, Denaro J, Hemenegildo N, et al (1992) A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch Neurol 49:492-497
38. McKeith IG, Galasko D, Kosaka K, et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 47:1113-1124
39. McKeith IG, Burn DJ, Ballard CG, et al (2003) Dementia with Lewy bodies. Semin Clin Neuropsychiatry 8:46-57
40. Micieli G, Tosi P, Marcheselli S, Cavallini A (2003) Autonomic dysfunction in Parkinson's disease. Neurol Sci 24(Suppl 1): S32-S34
41. Monta H, Shindo M, Ikeda S, Yanagisawa N (2000) Decrease in presynaptic inhibition on heteronymous monosynaptic Ia terminals in patients with Parkinson's disease. Mov Disord 15:830-834
42. Noth J, Podoll K, Friedemann HH (1985) Long-loop reflexes in small hand muscles studied in normal subjects and in patients with Huntington's disease. Brain 108:65-80
43. Noth J, Schurmann M, Podoll K, Schwarz M (1988) Reconsideration of the concept of enhanced static fusimotor drive in rigidity in patients with Parkinson's disease. Neurosci Lett 84:239-243
44. Polymeropoulos MH, Lavedan C, Leroy E, et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047
45. Rascol O, Goetz C, Koller W, Poewe W, Sampaio C (2002) Treatment interventions for Parkinson's disease: an evidence based assessment. Lancet 359:1589-1598
46. Sage JI, Miller DC, Golbe LI, Walters A, Duvoisin RC (1990) Clinically atypical expression of pathologically typical Lewy-body parkinsonism. Clin Neuropharmacol 13:36-47
47. Sakuma K, Nakashima K, Takahashi K (1996) Olfactory evoked potentials in Parkinson's disease, Alzheimer's disease and anosmic patients. Psychiatry Clin Neurosci 50:35-40
48. Sawle GV, Bloomfield PM, Björklund A, Brooks DJ, Brundin P, Leenders KL, et al (1992) Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants. Ann Neurol 31:166-173
49. Schrag A, Jahanshahi M, Quinn N (2000) What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 69:308-312
50. Siegert RJ, Harper DN, Cameron FB, Abernethy D (2002) Self-initiated versus externally cued reaction times in Parkinson's disease. J Clin Exp Neuropsychol 24:146-153
51. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839-840
52. Xia R, Rymer WZ (2004) The role of shortening reaction in mediating rigidity in Parkinson's disease. Exp Brain Res 156:524-528